Blood clotting and severity in sickle cell disease
Treatments studied
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation clinical trials.
This study looks at how the type and severity of sickle cell disease relate to blood clotting. They will take blood samples to understand this better, which may help improve future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 8 years old or older.
- You have been diagnosed with sickle cell disease (types S/S, S/beta0, or S/C).
- You have health insurance (social security or equivalent).
- You are not currently being treated for another condition in a way that might interfere.
- You have not had a blood transfusion or a therapeutic phlebotomy in the last 3 months.
- You are willing and able to give consent (or have a parent/guardian who can).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood cells in people with sickle cell disease and is done to better understand the disease. If you join, researchers will likely take a blood sample to see how your cells are working.
This trial looks at the cells that help make platelets (megakaryocytes) in people with sickle cell disease. By comparing these cells when you are feeling well and during a pain crisis or chest syndrome, researchers hope to learn more about the condition and find better treatments.
This study collects kidney tissue samples from people with sickle cell disease and healthy volunteers to better understand how sickle cell affects the kidneys. If you have sickle cell disease or a related blood disorder, you may help researchers find new ways to protect kidney function.
This study looks at how blood clots and platelets behave in people with the two most common types of sickle cell disease (SS and SC). It aims to understand differences that may help manage the disease better.
This study collects blood samples to learn more about sickle cell-related genetics and biology. You might benefit indirectly by helping researchers understand the condition, even though this is laboratory research rather than a medication trial.
This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.
Hear when a new Sickle Cell Disease (SCD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.